Tag: Inc.

64-Inch Wide DTFilm Printer Delivers Twin-Roll Flexibility, Automated Maintenance and High-Speed Production for Garment DecoratorsLOS ALAMITOS, Calif., June 10, 2026 /PRNewswire/ -- Epson today announced its...

As global football's ultimate spectacle kicks off on June 12, the 'Aleph Arena' digital hub will host one match per day and over 5,000...

The withdrawal does not reflect any change in the Company's business outlook, operating strategy, or confidence in the value of its assetsDALLAS, June 10,...

Worldwide launch of EARTH DEFENSE FORCE 5 scheduled for October 8, 2026; EARTH DEFENSE FORCE 6 planned for release this winterTOKYO, June 10, 2026...

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck from the offering are expected to be approximately $75 million before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Shattuck has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.

BCM solution debuts as new data reveals more than half of leaders overestimate their ability to recover from disrupted operations.LONDON, June 10, 2026 /PRNewswire/...

High Arctic Announces Management Changes

Minami Maeda appointed as CEO to drive faster, more focused execution toward U.S. commercial launchMickey Mikitani will continue to provide strategic direction and remains...

The same clinician-approved animations from the Hx Heart app are now available online at HxHeart.com — free, instantly, with no download required.BERKELEY, Calif., June...

LEXINGTON, Ky., June 9, 2026 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") today announced that Jeremy Sussman, Chief Financial...

Recognition highlights the impact of OPUS, the Orchestration Platform for Universal Solutions, in helping life sciences and healthcare companies digitalize multienterprise transactions and processes...